Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice
- 22 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (5) , 594-601
Abstract
Familial hypertrophic cardiomyopathy (FHC) is an inherited autosomal dominant disease caused by mutations in sarcomeric proteins. Among these, mutations that affect myosin binding protein-C (MyBP-C), an abundant component of the thick filaments, account for 20% to 30% of all mutations linked to FHC. However, the mechanisms by which MyBP-C mutations cause disease and the function of MyBP-C are not well understood. Therefore, to assess deficits due to elimination of MyBP-C, we used gene targeting to produce a knockout mouse that lacks MyBP-C in the heart. Knockout mice were produced by deletion of exons 3 to 10 from the endogenous cardiac (c) MyBP-C gene in murine embryonic stem (ES) cells and subsequent breeding of chimeric founder mice to obtain mice heterozygous (+/−) and homozygous (−/−) for the knockout allele. Wild-type (+/+), cMyBP-C +/− , and cMyBP-C −/− mice were born in accordance with Mendelian inheritance ratios, survived into adulthood, and were fertile. Western blot analyses confirmed that cMyBP-C was absent in hearts of homozygous knockout mice. Whereas cMyBP-C +/− mice were indistinguishable from wild-type littermates, cMyBP-C −/− mice exhibited significant cardiac hypertrophy. Cardiac function, assessed using 2-dimensionally guided M-mode echocardiography, showed significantly depressed indices of diastolic and systolic function only in cMyBP-C −/− mice. Ca 2+ sensitivity of tension, measured in single skinned myocytes, was reduced in cMyBP-C −/− but not cMyBP-C +/− mice. These results establish that cMyBP-C is not essential for cardiac development but that the absence of cMyBP-C results in profound cardiac hypertrophy and impaired contractile function.Keywords
This publication has 29 references indexed in Scilit:
- A role for C‐protein in the regulation of contraction and intracellular Ca2+ in intact rat ventricular myocytesThe Journal of Physiology, 2000
- Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heartThe Journal of Physiology, 1999
- Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C 1 1Edited by J. KarnJournal of Molecular Biology, 1999
- A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998
- Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.Proceedings of the National Academy of Sciences, 1993
- Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers.Journal of General Physiology, 1991
- Interaction of C-protein with pH 8.0 synthetic thick filaments prepared from the myosin of vertebrate skeletal muscleJournal of Muscle Research and Cell Motility, 1988
- H-protein and X-proteinJournal of Molecular Biology, 1983
- Phosphorylation of a myofibrillar protein of Mr 150 000 in perfused rat heart, and the tentative identification of this as C‐proteinFEBS Letters, 1980
- A new protein of the thick filaments of vertebrate skeletal myofibrilsJournal of Molecular Biology, 1973